Molecular Partners Ag Stock Price History
| MOLN Stock | USD 3.65 0.12 3.40% |
Below is the normalized historical share price chart for Molecular Partners AG extending back to June 16, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Molecular Partners stands at 3.65, as last reported on the 4th of August, with the highest price reaching 3.65 and the lowest price hitting 3.65 during the day.
If you're considering investing in Molecular Stock, it is important to understand the factors that can impact its price. Molecular Partners has Sharpe Ratio of -0.0452, which conveys that the firm had a -0.0452 % return per unit of risk over the last 3 months. Molecular Partners exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Molecular Partners' Mean Deviation of 2.78, standard deviation of 3.78, and Risk Adjusted Performance of 0.0019 to check out the risk estimate we provide.
At this time, Molecular Partners' Liabilities And Stockholders Equity is very stable compared to the past year. Sale Purchase Of Stock is expected to grow at the current pace this year, while Total Stockholder Equity is likely to drop about 138.8 M. . As of the 4th of August 2025, Price To Sales Ratio is likely to drop to 20.99. In addition to that, Price Earnings Ratio is likely to drop to -2.68. Molecular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of June 2021 | 200 Day MA 4.6169 | 50 Day MA 3.7487 | Beta 0.546 |
Molecular | Build AI portfolio with Molecular Stock |
Sharpe Ratio = -0.0452
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MOLN |
Estimated Market Risk
| 3.67 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Molecular Partners is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecular Partners by adding Molecular Partners to a well-diversified portfolio.
Price Book 0.826 | Enterprise Value Ebitda 1.2347 | Price Sales 61.9004 | Shares Float 11.4 M | Wall Street Target Price 10.694 |
Molecular Partners Stock Price History Chart
There are several ways to analyze Molecular Stock price data. The simplest method is using a basic Molecular candlestick price chart, which shows Molecular Partners price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | May 12, 2025 | 4.28 |
| Lowest Price | August 1, 2025 | 3.53 |
Molecular Partners August 4, 2025 Stock Price Synopsis
Various analyses of Molecular Partners' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Molecular Stock. It can be used to describe the percentage change in the price of Molecular Partners from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Molecular Stock.| Molecular Partners Price Rate Of Daily Change | 1.03 | |
| Molecular Partners Price Action Indicator | 0.06 |
Molecular Partners August 4, 2025 Stock Price Analysis
Molecular Stock Price History Data
The price series of Molecular Partners for the period between Tue, May 6, 2025 and Mon, Aug 4, 2025 has a statistical range of 0.75 with a coefficient of variation of 4.76. The daily prices for the period are spread out with arithmetic mean of 3.81. The median price for the last 90 days is 3.81.| Open | High | Low | Close | Volume | ||
08/04/2025 | 3.65 | 3.65 | 3.65 | 3.65 | 675.00 | |
08/01/2025 | 3.41 | 3.53 | 3.41 | 3.53 | 424.00 | |
07/31/2025 | 3.70 | 3.70 | 3.70 | 3.70 | 270.00 | |
07/30/2025 | 3.75 | 3.85 | 3.65 | 3.80 | 1,116 | |
| 07/29/2025 | 3.96 | 3.96 | 3.92 | 3.95 | 1,380 | |
07/28/2025 | 3.95 | 3.95 | 3.94 | 3.94 | 938.00 | |
07/25/2025 | 4.00 | 4.00 | 3.83 | 3.87 | 2,113 | |
| 07/24/2025 | 3.95 | 4.00 | 3.83 | 4.00 | 1,976 | |
07/23/2025 | 3.90 | 3.90 | 3.90 | 3.90 | 889.00 | |
07/22/2025 | 3.85 | 3.85 | 3.73 | 3.73 | 881.00 | |
07/21/2025 | 3.78 | 3.87 | 3.78 | 3.85 | 1,572 | |
07/18/2025 | 3.60 | 3.60 | 3.60 | 3.60 | 408.00 | |
07/17/2025 | 3.57 | 3.66 | 3.57 | 3.65 | 1,367 | |
07/16/2025 | 3.57 | 3.70 | 3.55 | 3.65 | 1,825 | |
07/15/2025 | 3.62 | 3.62 | 3.57 | 3.57 | 631.00 | |
07/14/2025 | 3.51 | 3.55 | 3.51 | 3.55 | 735.00 | |
07/11/2025 | 3.59 | 3.59 | 3.59 | 3.59 | 497.00 | |
07/10/2025 | 3.60 | 3.60 | 3.55 | 3.55 | 1,050 | |
07/09/2025 | 3.58 | 3.58 | 3.58 | 3.58 | 184.00 | |
07/08/2025 | 3.68 | 3.68 | 3.58 | 3.58 | 184.00 | |
07/07/2025 | 3.76 | 3.76 | 3.61 | 3.61 | 2,184 | |
07/03/2025 | 3.76 | 3.76 | 3.76 | 3.76 | 97.00 | |
07/02/2025 | 3.74 | 3.76 | 3.74 | 3.76 | 638.00 | |
07/01/2025 | 3.73 | 3.84 | 3.71 | 3.71 | 710.00 | |
06/30/2025 | 3.74 | 3.89 | 3.74 | 3.82 | 1,590 | |
06/27/2025 | 3.67 | 3.76 | 3.63 | 3.76 | 7,902 | |
06/26/2025 | 3.66 | 3.86 | 3.58 | 3.58 | 5,613 | |
06/25/2025 | 3.71 | 3.71 | 3.68 | 3.69 | 2,515 | |
06/24/2025 | 3.58 | 3.58 | 3.58 | 3.58 | 244.00 | |
06/23/2025 | 3.90 | 3.90 | 3.50 | 3.58 | 3,191 | |
06/20/2025 | 3.89 | 3.89 | 3.89 | 3.89 | 285.00 | |
06/18/2025 | 3.82 | 3.82 | 3.82 | 3.82 | 400.00 | |
06/17/2025 | 4.13 | 4.13 | 3.76 | 3.76 | 2,822 | |
06/16/2025 | 3.94 | 3.95 | 3.84 | 3.84 | 2,375 | |
06/13/2025 | 3.68 | 4.12 | 3.68 | 3.84 | 2,053 | |
06/12/2025 | 3.75 | 3.90 | 3.75 | 3.90 | 797.00 | |
| 06/11/2025 | 3.61 | 3.61 | 3.61 | 3.61 | 882.00 | |
| 06/10/2025 | 3.97 | 3.97 | 3.70 | 3.70 | 924.00 | |
06/09/2025 | 3.80 | 3.89 | 3.80 | 3.89 | 657.00 | |
06/06/2025 | 3.59 | 3.80 | 3.58 | 3.80 | 1,595 | |
06/05/2025 | 3.64 | 3.64 | 3.51 | 3.56 | 1,273 | |
06/04/2025 | 3.59 | 3.65 | 3.56 | 3.65 | 3,400 | |
06/03/2025 | 3.81 | 3.82 | 3.55 | 3.59 | 8,185 | |
06/02/2025 | 3.62 | 3.80 | 3.62 | 3.79 | 3,022 | |
05/30/2025 | 3.86 | 4.08 | 3.81 | 3.81 | 2,473 | |
05/29/2025 | 3.58 | 3.58 | 3.58 | 3.58 | 680.00 | |
05/28/2025 | 4.05 | 4.05 | 4.05 | 4.05 | 1,139 | |
05/27/2025 | 3.95 | 4.06 | 3.95 | 4.06 | 1,997 | |
05/23/2025 | 3.95 | 4.11 | 3.87 | 4.04 | 10,089 | |
05/22/2025 | 3.90 | 3.90 | 3.89 | 3.89 | 4,133 | |
05/21/2025 | 3.94 | 3.94 | 3.94 | 3.94 | 202.00 | |
| 05/20/2025 | 4.17 | 4.17 | 3.94 | 3.94 | 202.00 | |
05/19/2025 | 3.90 | 3.95 | 3.90 | 3.95 | 1,013 | |
05/16/2025 | 3.89 | 3.89 | 3.84 | 3.84 | 1,072 | |
05/15/2025 | 3.91 | 4.03 | 3.85 | 3.85 | 6,602 | |
| 05/14/2025 | 3.92 | 3.97 | 3.90 | 3.91 | 2,122 | |
05/13/2025 | 4.18 | 4.18 | 3.89 | 3.98 | 5,334 | |
05/12/2025 | 4.04 | 4.28 | 4.04 | 4.28 | 1,531 | |
05/09/2025 | 4.01 | 4.10 | 3.95 | 4.10 | 2,776 | |
05/08/2025 | 4.22 | 4.22 | 3.96 | 3.96 | 2,851 | |
05/07/2025 | 4.00 | 4.23 | 3.79 | 4.23 | 2,525 |
About Molecular Partners Stock history
Molecular Partners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Molecular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Molecular Partners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Molecular Partners stock prices may prove useful in developing a viable investing in Molecular Partners
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 34 M | 27 M | |
| Net Income Applicable To Common Shares | 135.5 M | 142.3 M |
Molecular Partners Quarterly Net Working Capital |
|
Molecular Partners Stock Technical Analysis
Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Molecular Partners Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Molecular Partners' price direction in advance. Along with the technical and fundamental analysis of Molecular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Molecular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0019 | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.04) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.09) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.